Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Interest & Investment Income (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Interest & Investment Income data on record, last reported at $1.2 million in Q3 2025.

  • For Q3 2025, Interest & Investment Income changed N/A year-over-year to $1.2 million; the TTM value through Sep 2025 reached $2.3 million, changed N/A, while the annual FY2023 figure was $1.7 million, 8.06% down from the prior year.
  • Interest & Investment Income reached $1.2 million in Q3 2025 per TNXP's latest filing, up from $1000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.2 million in Q3 2025 and bottomed at $1000.0 in Q2 2024.
  • Average Interest & Investment Income over 3 years is $575250.0, with a median of $534500.0 recorded in 2023.